Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K van Besien

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|March 29, 2011
Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantationS R Marino, S Lin, M Maiers, et al.
Bone Marrow Transplantation|November 16, 2004
Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago ExperienceA S Artz, K Van Besien, T Zimmerman, et al.
Blood|October 15, 1993
Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myelomaM A Dimopoulos, R Alexanian, D Przepiorka, et al.
Bone Marrow Transplantation|October 6, 1997
Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovirC Ippoliti, A Morgan, D Warkentin, et al.
Blood|September 6, 2001
Chronic graft-versus-host disease after allogeneic blood stem cell transplantationD Przepiorka, P Anderlini, R Saliba, et al.
Gynecologic Oncology|May 1, 1997
Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescueK van Besien, C Verschraegen, R Mehra, et al.
Blood|March 15, 1995
Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allograftsM Körbling, D Przepiorka, Y O Huh, et al.
Bone Marrow Transplantation|October 3, 2017
Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donorsC Liu, D N Frank, M Horch, et al.
Bone Marrow Transplantation|January 10, 2006
Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioningJ Kline, D A Pollyea, W Stock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignanciesS A Giralt, C F LeMaistre, H M Vriesendorp, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|March 29, 2011
Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantationS R Marino, S Lin, M Maiers, et al.
Bone Marrow Transplantation|November 16, 2004
Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago ExperienceA S Artz, K Van Besien, T Zimmerman, et al.
Blood|October 15, 1993
Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myelomaM A Dimopoulos, R Alexanian, D Przepiorka, et al.
Bone Marrow Transplantation|October 6, 1997
Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovirC Ippoliti, A Morgan, D Warkentin, et al.
Blood|September 6, 2001
Chronic graft-versus-host disease after allogeneic blood stem cell transplantationD Przepiorka, P Anderlini, R Saliba, et al.
Gynecologic Oncology|May 1, 1997
Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescueK van Besien, C Verschraegen, R Mehra, et al.
Blood|March 15, 1995
Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allograftsM Körbling, D Przepiorka, Y O Huh, et al.
Bone Marrow Transplantation|October 3, 2017
Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donorsC Liu, D N Frank, M Horch, et al.
Bone Marrow Transplantation|January 10, 2006
Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioningJ Kline, D A Pollyea, W Stock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignanciesS A Giralt, C F LeMaistre, H M Vriesendorp, et al.
Pageof 8